Afrezza (Insulin Human) Inhalation Powder: A New Inhaled Insulin for the Management Of Type-1 or Type-2 Diabetes Mellitus.
Afrezza (insulin human) inhalation powder: a new inhaled insulin for the management of type-1 or type-2 diabetes mellitus.
| Publicado en: | P&T: A Peer-Reviewed Journal for Managed Care & Formulary Management Vol. 40; no. 11; pp. 735 - 742 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
MediMedia Managed Markets, an ICON Company
Nov2015
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=146152704&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 146152704 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10521372 25J5 jtl: P&T: A Peer-Reviewed Journal for Managed Care & Formulary Management issn: 10521372 maglogo: N pubinfo: dt: Nov2015 vid: 40 iid: 11 pid: 29351 pub: MediMedia Managed Markets, an ICON Company place: Yardley, Pennsylvania artinfo: ui: 146152704 110710262 NLM26609206 NLM26609206 146152704 ppf: 735 ppct: 7 formats: fmt: @attributes: type: P tig: atl: Afrezza (Insulin Human) Inhalation Powder: A New Inhaled Insulin for the Management Of Type-1 or Type-2 Diabetes Mellitus. aug: au: Goldberg, Tamara Wong, Elaine sug: ab: Afrezza (insulin human) inhalation powder: a new inhaled insulin for the management of type-1 or type-2 diabetes mellitus. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|